The emerging role of radioimmunotherapy in haematological malignancies.
Illidge
T M
TM
CRC Oncology Unit, Cancer Sciences Division, Southampton University School of Medicine, Southampton General Hospital, Southampton SO16 6YD, UK.
Johnson
P W
PW
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D018951:Antigens, CD20 / Q000276:immunology; D019337:Hematologic Neoplasms / Q000532:radiotherapy*; D006801:Humans; D017493:Leukocyte Common Antigens / Q000276:immunology; D008223:Lymphoma / Q000532:radiotherapy; D016499:Radioimmunotherapy / Q000379:methods*; D011868:Radioisotopes / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D018951:Antigens, CD20; D011868:Radioisotopes; D017493:Leukocyte Common Antigens